Navigation Links
Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Date:3/18/2011

All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10- Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of March 18, 2011 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modelled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
2. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
3. Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
4. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
5. Call for Applications: The Amgen Award for Science Teaching Excellence
6. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
7. Amgen to Provide Testimony at FDA Hearing on Biosimilars
8. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
9. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
10. Array BioPharma and Amgen Partner in Type 2 Diabetes
11. Amgen to Present at Lazard Capital Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
(Date:6/30/2015)... 2015  NASA astronaut Kjell Lindgren , who is ... first mission to the International Space Station , will ... a.m. EDT Tuesday, July 7. Lindgren will participate ... Russia . The interviews will be preceded at ... mission training. To schedule an interview, media must ...
(Date:6/30/2015)... 30, 2015  Today, Americord Registry, one of the fastest ... Horne , a partner at Kirkland & Ellis LLP, as ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled ... says Martin Smithmyer , CEO of Americord. "He brings ... that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... Kent, WA (PRWEB) , ... June 30, 2015 ... ... offers a hydrophilic filter that does not sacrifice selectivity to achieve faster flow ... construction combines extremely fine pores with significant open space to allow easy liquid ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Americord Registry Announces Andrew Horne as Advisory Board Member 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... Guava Technologies today,launched a new corporate website with ... Flow Cytometrists, and Clinicians. With flow cytometry ... is dedicated to finding innovative ways to make ... scientists and clinicians who work,with cells. This dedication ...
... 07/06 ... ... 17 Other EU countries (2) 7.07 24.2 6.06 24.4 17 Other markets ... SLIT 22.13 75.8 18.14 72.9 ...
... TUSTIN, Calif., Oct. 11 AMDL, Inc. ... in Shenzhen,Jiangxi and Jilin, China, through its ... an international biopharma company that,engages in the ... diagnostic products. AMDL announced today that JPI ...
Cached Biology Technology:New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians 2Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17% 2AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually 2
(Date:6/12/2015)... 12, 2015  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announced the ... electronically capture, analyze and identify participants of a ... This system can: , ... and subsequent sign-on process is actually the person ...
(Date:6/9/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... will be providing demonstrations of its iMedNet ... Information Association (DIA) Annual Meeting in Washington ... include previews of many exciting new enhancements that will ... 2015 Feature 1 Release. MedNet ...
(Date:6/8/2015)... -- The Secure Identity & Biometrics Association ... Potter of L-3 National Security Solutions (NSS) ... association that was established in February 2014 to ... solutions that protect and secure identity across private ... Photo - http://photos.prnewswire.com/prnh/20150605/221167 ...
Breaking Biology News(10 mins):Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... BOZEMAN, Mont. -- Controlling Japanese B encephalitis ... brain-injuring virus needs mosquitoes and pigs to spread, government ... urban drainage ditches. They should keep industrial "piggeries" away ... from industrial disease are much more complex than that, ...
... populations in threatened forests are far more sensitive to ... new research. An analysis of monkeys living in ... factors, such as human activity, on species numbers is ... Researchers also found that the health of monkey ...
... breakthrough of a lifetime, turning discarded fruit peels and other ... University of Central Florida professor Henry Daniell has developed ... as orange peels and newspapers. His approach is greener and ... on cleaner fuel and his goal is to relegate ...
Cached Biology News:Environmental historian now tackles industrial disease in Japan 2Environmental historian now tackles industrial disease in Japan 3Environmental historian now tackles industrial disease in Japan 4Orange peels, newspapers may lead to cheaper, cleaner ethanol fuel 2
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... expertise that made the original Gene Pulser apparatus ... available has been applied in the Gene Pulser ... modular design of the Gene Pulser II system ... that has the widest range of settings to ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Pro260 reagents and supplies, for 10 ... sufficient to perform protein analysis with ... electrophoresis system. Supplied are 3 x ... Pro260 stain, 60 microliters Pro260 ladder ...
Biology Products: